Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

A longitudinal study of the metabolic syndrome and risk of colorectal cancer in postmenopausal women.

Kabat GC, Kim MY, Peters U, Stefanick M, Hou L, Wactawski-Wende J, Messina C, Shikany JM, Rohan TE.

Eur J Cancer Prev. 2012 Jul;21(4):326-32. doi: 10.1097/CEJ.0b013e32834dbc81.

PMID:
22044849
2.

A longitudinal study of the metabolic syndrome and risk of postmenopausal breast cancer.

Kabat GC, Kim M, Chlebowski RT, Khandekar J, Ko MG, McTiernan A, Neuhouser ML, Parker DR, Shikany JM, Stefanick ML, Thomson CA, Rohan TE.

Cancer Epidemiol Biomarkers Prev. 2009 Jul;18(7):2046-53. doi: 10.1158/1055-9965.EPI-09-0235. Epub 2009 Jun 30.

3.

Repeated measurements of serum carotenoid, retinol and tocopherol levels in relation to colorectal cancer risk in the Women's Health Initiative.

Kabat GC, Kim MY, Sarto GE, Shikany JM, Rohan TE.

Eur J Clin Nutr. 2012 May;66(5):549-54. doi: 10.1038/ejcn.2011.207. Epub 2011 Dec 14.

PMID:
22166899
4.

A longitudinal study of serum insulin and glucose levels in relation to colorectal cancer risk among postmenopausal women.

Kabat GC, Kim MY, Strickler HD, Shikany JM, Lane D, Luo J, Ning Y, Gunter MJ, Rohan TE.

Br J Cancer. 2012 Jan 3;106(1):227-32. doi: 10.1038/bjc.2011.512. Epub 2011 Nov 29.

5.

The metabolic syndrome and risk of incident colorectal cancer.

Ahmed RL, Schmitz KH, Anderson KE, Rosamond WD, Folsom AR.

Cancer. 2006 Jul 1;107(1):28-36.

6.

Metabolic risk factors and skin cancer in the Metabolic Syndrome and Cancer Project (Me-Can).

Nagel G, Bjørge T, Stocks T, Manjer J, Hallmans G, Edlinger M, Häggström C, Engeland A, Johansen D, Kleiner A, Selmer R, Ulmer H, Tretli S, Jonsson H, Concin H, Stattin P, Lukanova A.

Br J Dermatol. 2012 Jul;167(1):59-67. doi: 10.1111/j.1365-2133.2012.10974.x. Epub 2012 Apr 24.

PMID:
22530854
7.

Metabolic syndrome is associated with increased risk of recurrent colorectal adenomas in Korean men.

Kim MC, Jung SW, Kim CS, Chung TH, Yoo CI, Park NH.

Int J Obes (Lond). 2012 Jul;36(7):1007-11. doi: 10.1038/ijo.2011.177. Epub 2011 Sep 6.

PMID:
21894158
8.

Prospective study of leukocyte count as a predictor of incident breast, colorectal, endometrial, and lung cancer and mortality in postmenopausal women.

Margolis KL, Rodabough RJ, Thomson CA, Lopez AM, McTiernan A; Women's Health Initiative Research Group..

Arch Intern Med. 2007 Sep 24;167(17):1837-44.

PMID:
17893304
9.

Metabolic factors and the risk of colorectal cancer in 580,000 men and women in the metabolic syndrome and cancer project (Me-Can).

Stocks T, Lukanova A, Bjørge T, Ulmer H, Manjer J, Almquist M, Concin H, Engeland A, Hallmans G, Nagel G, Tretli S, Veierød MB, Jonsson H, Stattin P; Metabolic Syndrome Cancer Project Me-Can Group..

Cancer. 2011 Jun 1;117(11):2398-407. doi: 10.1002/cncr.25772. Epub 2010 Dec 17.

10.

Colorectal cancer incidence and postmenopausal hormone use by type, recency, and duration in cancer prevention study II.

Hildebrand JS, Jacobs EJ, Campbell PT, McCullough ML, Teras LR, Thun MJ, Gapstur SM.

Cancer Epidemiol Biomarkers Prev. 2009 Nov;18(11):2835-41. doi: 10.1158/1055-9965.EPI-09-0596. Epub 2009 Oct 20.

11.

Association between cigarette smoking and colorectal cancer in the Women's Health Initiative.

Paskett ED, Reeves KW, Rohan TE, Allison MA, Williams CD, Messina CR, Whitlock E, Sato A, Hunt JR.

J Natl Cancer Inst. 2007 Nov 21;99(22):1729-35. Epub 2007 Nov 13.

PMID:
18000222
12.

Diabetes mellitus and subsite-specific colorectal cancer risks in the Iowa Women's Health Study.

Limburg PJ, Anderson KE, Johnson TW, Jacobs DR Jr, Lazovich D, Hong CP, Nicodemus KK, Folsom AR.

Cancer Epidemiol Biomarkers Prev. 2005 Jan;14(1):133-7.

13.

C-reactive protein levels are not associated with increased risk for colorectal cancer in women.

Zhang SM, Buring JE, Lee IM, Cook NR, Ridker PM.

Ann Intern Med. 2005 Mar 15;142(6):425-32.

PMID:
15767620
14.

Serum high-density lipoprotein cholesterol, metabolic profile, and breast cancer risk.

Furberg AS, Veierød MB, Wilsgaard T, Bernstein L, Thune I.

J Natl Cancer Inst. 2004 Aug 4;96(15):1152-60.

PMID:
15292387
15.

Components of the metabolic syndrome and colorectal cancer risk; a prospective study.

Stocks T, Lukanova A, Johansson M, Rinaldi S, Palmqvist R, Hallmans G, Kaaks R, Stattin P.

Int J Obes (Lond). 2008 Feb;32(2):304-14. Epub 2007 Sep 18.

PMID:
17878894
16.

Novel metabolic risk factors for incident heart failure and their relationship with obesity: the MESA (Multi-Ethnic Study of Atherosclerosis) study.

Bahrami H, Bluemke DA, Kronmal R, Bertoni AG, Lloyd-Jones DM, Shahar E, Szklo M, Lima JA.

J Am Coll Cardiol. 2008 May 6;51(18):1775-83. doi: 10.1016/j.jacc.2007.12.048.

17.

Reproductive and menstrual factors and risk of ductal carcinoma in situ of the breast in a cohort of postmenopausal women.

Kabat GC, Kim MY, Woods NF, Habel LA, Messina CR, Wactawski-Wende J, Stefanick ML, Chlebowski RT, Wassertheil-Smoller S, Rohan TE.

Cancer Causes Control. 2011 Oct;22(10):1415-24. doi: 10.1007/s10552-011-9814-8. Epub 2011 Jul 13.

PMID:
21750889
18.

Colorectal cancer mortality and factors related to the insulin resistance syndrome.

Colangelo LA, Gapstur SM, Gann PH, Dyer AR, Liu K.

Cancer Epidemiol Biomarkers Prev. 2002 Apr;11(4):385-91.

19.

Lack of evidence for effect modification by estrogen of association between body mass index and colorectal cancer risk among postmenopausal women.

Wang Y, Jacobs EJ, Teras LR, Pavluck AL, Rodriguez C, Thun MJ, Calle EE.

Cancer Causes Control. 2007 Oct;18(8):793-9. Epub 2007 Jul 6.

PMID:
17619155
20.

Time-dependent association between metabolic syndrome and risk of CKD in Korean men without hypertension or diabetes.

Ryu S, Chang Y, Woo HY, Lee KB, Kim SG, Kim DI, Kim WS, Suh BS, Jeong C, Yoon K.

Am J Kidney Dis. 2009 Jan;53(1):59-69. doi: 10.1053/j.ajkd.2008.07.027. Epub 2008 Oct 5. Erratum in: Am J Kidney Dis. 2009 May;53(5):913.

PMID:
18838200

Supplemental Content

Support Center